A weight loss condition that affects patients with cancer has provided clues as to why cancer immunotherapy – a new approach to treating cancer by boosting a patient’s immune system – may fail in a substantial number of patients.
An international study of almost 120,000 women has newly identified five genetic variants affecting risk of breast cancer, all of which are believed to influence how breast cells respond to the female sex hormone oestrogen.
Launched today (26 September), Cancer Core Europe brings together six cancer centres – including the Cambridge Cancer Centre at the University of Cambridge – to link cancer research through to cancer care.
Men who eat over 10 portions a week of tomatoes have an 18 per cent lower risk of developing prostate cancer, new research suggests.
Research will make the study of diseases such as Parkinson’s and Alzheimer’s easier, and could lead to personalised therapies for a variety of neurodegenerative disorders.
Members of the University have been recognised for their outstanding contributions to society
Study shows better overall cosmetic results for women treated using intensity modulated radiation therapy (IMRT).
The Royal Society has awarded three University academics for their ground-breaking research that will help to forward the future of science.
Over 80 regions of the genome that can increase an individual’s risk of breast, prostate and ovarian cancers have been found in the largest ever study of its kind.
Cambridge scientists have honed techniques originally developed to spot distant galaxies and used them to identify biomarkers that signal a cancer’s aggressiveness.
© 2024 University of Cambridge